05 / Our capabilities
Manufacturing & Supply Chain
Establishing manufacturing or sourcing in Mexico requires more than finding a supplier. Pharmaceutical and medical-technology supply chains must also demonstrate suitable quality systems, traceability and documented control of relevant risks.
The challenge
Establishing manufacturing or sourcing in Mexico requires more than finding a supplier. Pharmaceutical and medical-technology supply chains must also demonstrate suitable quality systems, traceability and documented control of relevant risks.
How CRMevidence could support
Assess local sourcing and nearshoring options; screen manufacturing and logistics partners; define risk-based supplier qualification criteria; coordinate quality-system assessments and supplier audits; review relevant GMP, GDP or ISO 13485 expectations where applicable; assess documentation, traceability, change control, deviations and corrective and preventive actions (CAPA). Support make-or-buy analysis, import interfaces and industrialisation planning.
Potential project outputs
A supplier longlist and qualification matrix, proposed audit plan, quality and compliance gap register, CAPA follow-up structure, sourcing scenarios and a phased supply-chain implementation roadmap.
Important qualification
GMP, GDP, ISO 13485 and other standards apply differently across product types and activities. ISO certification does not automatically establish regulatory compliance. Regulated audits, certification and final supplier approval require appropriately qualified and authorised parties. CRMevidence’s capacity to provide or coordinate these services is pending confirmation.
Additional detail from CRMevidence corporate profile (November 2026)
The corporate profile identifies supplier and manufacturing-partner assessment, sourcing, import-versus-localisation decisions, industrial readiness, landed-cost and margin analysis, distribution economics, inventory planning and nearshoring feasibility.
Proposed service scope. Subject to confirmation by CRMevidence.